Answers are grounded in this paper and cite their sources.
In British Columbia, Canada, clinical guidelines for the treatment of opioid use disorders (OUD) were updated in 2017, during a period in which the potency and composition of the illicit drug supply changed rapidly. We aimed to describe changes in opioid agonist treatment (OAT) prescribing practices at the population level in a setting in which fentanyl and its analogs have become the primary illicit opioid of use.
No takes yet. Share an insight, caveat, or question.
Guerra‐Alejos et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: